BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33206693)

  • 1. Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?
    Chiesa A; Ochola E; Oreni L; Vassalini P; Rizzardini G; Galli M
    PLoS One; 2020; 15(11):e0242278. PubMed ID: 33206693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
    Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia.
    Wasihun Y; Asnake D; Kebede N
    BMC Infect Dis; 2024 May; 24(1):460. PubMed ID: 38693473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
    Mayanja Y; Rida W; Kimani J; Ssetala A; Mpendo J; Nanvubya A; Mutua G; Anzala O; Price MA
    PLoS One; 2023; 18(7):e0288604. PubMed ID: 37459311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
    Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
    BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia.
    Weldemhret L; Asmelash T; Belodu R; Gebreegziabiher D
    AIDS Res Ther; 2016; 13():6. PubMed ID: 26855663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana.
    Kye-Duodu G; Nortey P; Malm K; Nyarko KM; Sackey SO; Ofori S; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):7. PubMed ID: 28210375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
    Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ
    Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
    Ocama P; Seremba E; Apica B; Opio K
    Afr Health Sci; 2015 Jun; 15(2):328-33. PubMed ID: 26124776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis-B virus co-infection among people living with HIV in Mthatha region of South Africa.
    Kaswa R; de Villiers M
    Afr Health Sci; 2023 Mar; 23(1):149-156. PubMed ID: 37545964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
    Wandeler G; Musukuma K; Zürcher S; Vinikoor MJ; Llenas-García J; Aly MM; Mulenga L; Chi BH; Ehmer J; Hobbins MA; Bolton-Moore C; Hoffmann CJ; Egger M;
    PLoS One; 2016; 11(3):e0152043. PubMed ID: 27032097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance.
    Bautista-Amorocho H; Castellanos-Domínguez YZ; Rodríguez-Villamizar LA; Velandia-Cruz SA; Becerra-Peña JA; Farfán-García AE
    PLoS One; 2014; 9(12):e114272. PubMed ID: 25462190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of maternal HIV-HBV coinfection on pregnancy outcomes in an underdeveloped rural area of southwest China.
    Li C; Yang Y; Wang Y; Dong S; Yang Y; Shi Y; Li L; Jiang F; Chen Y; Jiang Q; Zhou Y
    Sex Transm Infect; 2020 Nov; 96(7):509-515. PubMed ID: 31911426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
    Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
    BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.